Crossmark

Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza

Crossref DOI link: https://doi.org/10.1186/s13613-023-01207-9

Published Print: 2023

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Laurichesse, Guillaume

Schwebel, Carole

Buetti, Niccolò

Neuville, Mathilde

Siami, Shidasp

Cohen, Yves

Laurent, Virginie

Mourvillier, Bruno

Reignier, Jean

Goldgran‐Toledano, Dany

Ruckly, Stéphane

de Montmollin, Etienne

Souweine, Bertrand

Timsit, Jean‐François

Dupuis, Claire https://orcid.org/0000-0002-3533-3097
Funding

Funding for this research was provided by:

Pfizer
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-023-01207-9

Content Type: article

Copyright: Copyright © 2023 The Author(s) 2023. Published by Elsevier Masson SAS